Trademark: 98433749
Word
BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV
Status
Pending
Status Code
630
Status Date
Tuesday, March 5, 2024
Serial Number
98433749
Mark Type
0000
Filing Date
Tuesday, March 5, 2024
Trademark Owner History
TG Therapeutics, Inc.
Classifications
44 Providing health information
The mark consists of the text "BRIUMVI" in black above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" in dark grey with the "B" in "BRIUMVI" partially surrounded by a light blue sphere edged in gold.
The color(s) black, dark grey, light blue and gold is/are claimed as a feature of the mark.
The wording BRIUMVI has no meaning in a foreign language.
"150 MG/6ML INJECTION FOR IV"
Trademark Events
Mar 5, 2024
New Application Entered
360 NATURE'S IMPACT
EDGEWATER
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov